X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Burroughs Wellcome: Results reflective of continuing domestic slowdown - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
  • Home
  • Outlook Arena
  • Apr 26, 2000 - Burroughs Wellcome: Results reflective of continuing domestic slowdown

Burroughs Wellcome: Results reflective of continuing domestic slowdown

Apr 26, 2000

Burroughs Wellcome has a relatively older product range vis–a-Glaxo. Quite a few products such as Septran, Actified, Banocide have actually shown a degrowth last year ranging from 6 to 10%. The trend seems to be continuing in the first quarter of the current year as evidenced by the 2.7% growth in the topline. Also, till the last year exports of Trimethoprim to the parent were substantial. These were stopped and a one time clearing of stocks contributed more than half of the post tax profits. In the absence of these incomes in the current year, post tax profits have dropped by 50%.

(Rs m) FY1999 FY2000 Change
Sales 327 336 2.7%
Other Income 23 30 28.1%
Expenditure 296 311 5.2%
Operating Profit (EBDIT) 31 24 -20.8%
Operating Profit Margin (%) 9% 7%  
Interest 7 5 -18.2%
Depreciation 6 6 0.0%
Profit before Tax 42 43 3.1%
Other Adjustments 42    
Tax 29 16 -44.6%
Profit after Tax/(Loss) 55 27 -50.9%
Net profit margin (%) 16.7% 8.0%  


Equitymaster requests your view! Post a comment on "Burroughs Wellcome: Results reflective of continuing domestic slowdown". Click here!

  

More Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BURROUGH WEL

  • Track your investment in BURROUGH WEL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS